5-[4-(2-FLUOROETHYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE
Compound with spectra: 1 NMR
![5-[4-(2-FLUOROETHYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE](/api/compound/CtreINNaY8Y.png?ph=true&h=300&w=458 "5-[4-(2-FLUOROETHYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE")
| SpectraBase Compound ID | CtreINNaY8Y |
|---|---|
| InChI | InChI=1S/C17H16FN3OS/c1-17(7-8-18)13-9-11(3-5-14(13)20-16(23)22-17)15-6-4-12(10-19)21(15)2/h3-6,9H,7-8H2,1-2H3,(H,20,23) |
| InChIKey | UECRKPRISWFXTM-UHFFFAOYSA-N |
| Mol Weight | 329.39 g/mol |
| Molecular Formula | C17H16FN3OS |
| Exact Mass | 329.099811 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
5-[4-(3-FLUOROPROPYL)-4-METHYL-2-THIOXO-1,4-DIHYDRO-2-H-BENZO-[D]-[1.3]-OXAZIN-6-YL]-1-METHYL-1-H-PYRROLE-2-CARBONITRILE
1-PHENYL-PENTALONGIN
OKLXWNDODXFSCM-KOFCSXQLSA-N
9-[3.beta.-Acetamido-2.alpha.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]-6-dimethylaminopurine
9-[3.beta.-Acetamido-2.beta.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]-6-dimethylaminopurine
4-cyclohexyl-6-methyl-5,6-dihydro-3H-benzo[f]isoquinolin-2-one
ETHYL-5-PHENYL-4-FLUORO-3-CYANOMETHYL-1-BENZYL-1H-PYRROLE-2-CARBOXYLATE
1-(3,5-dimethylphenyl)-4-[(4Z)-4-[(2-sulfanylidenepropyl)imino]-6,8-dioxabicyclo[3.2.1]octan-2-yl]-4,5-dihydro-1H-1,2,3,4-tetrazole-5-thione
benzamide, 4-methyl-N-[(5Z)-4-oxo-5-[[1-phenyl-3-(2-thienyl)-1H-pyrazol-4-yl]methylene]-2-thioxothiazolidinyl]-
2-[5-(2-chlorophenyl)-2-furanyl]-N-(4-fluorophenyl)-4-quinolinecarboxamide
| Title | Journal or Book | Year |
|---|---|---|
| Imaging Progesterone Receptor in Breast Tumors: Synthesis and Receptor Binding Affinity of Fluoroalkyl-Substituted Analogues of Tanaproget | Journal of Medicinal Chemistry | 2010 |